Considering the high incidence of cancers arising in the digestive system (19) and the frequency of 1.4% of MLH1-/PMS2-/MSH6- cases across the included entities, a considerable number of patients could fall into this subgroup overall. This evidence concerns the gene MSH6 and cancer.